Normal view MARC view ISBD view

Diet selection and live-weight changes of two breeds of goats grazing on heathlands. [electronic resource]

By:

Osoro, K

Contributor(s):

Producer: 20121002Description: 449-57 p. digitalISSN:

1751-7311

Online resources:

Available from publisher's website

In: Animal : an international journal of animal bioscience vol. 1

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

126681 Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
by Forbes, Amanda
126682 Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
by Kanwal, Rajnee
126683 Web-based versus in-person methods for training lay community health advisors to implement health promotion workshops: participant outcomes from a cluster-randomized trial.
by Holt, Cheryl L
126684 Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.
by Li, Qiuhui
126685 Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.
by Cattrini, Carlo
126686 Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo.
by Mapoung, Sariya
126687 Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.
by Chen, Yanhua
126688 Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.
by Song, Bing
126689 MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer.
by Nickols, Nicholas G
126690 Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer.
by Sumiyoshi, Takayuki
126691 Specific zinc finger-induced methylation of PD-L1 promoter inhibits its expression.
by Li, Xue
126692 Clinical characteristics, treatment pattern, and medical costs associated with metastatic castration-resistant prostate cancer in Chinese tertiary care hospital settings.
by Qian, Zhaoxin
126693 Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients.
by Nicosia, Luca
126694 Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer.
by Mager, Rene
126695 None
by van Steenbergen, T R F
126696 The role of WNT10B in normal prostate gland development and prostate cancer.
by Madueke, Ikenna
126697 Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study.
by Pan, Jiahua
126698 Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
by Rabin-Court, Aviva
126699 Management of erectile dysfunction after prostate cancer treatment: cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK.
by Dyer, Amy
126700 Race, tumor location, and disease progression among low-risk prostate cancer patients.
by Mygatt, Justin G